MediGene AG | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,264.00
5,912.00
13,399.00
9,720.00
12,939.00
17,004
Depreciation, Depletion & Amortization
751.00
810.00
944.00
845.00
1,267.00
1,572
Other Funds
-
-
-
42.00
88.00
196
Funds from Operations
10,938.00
5,688.00
12,694.00
16,830.00
14,332.00
15,236
Changes in Working Capital
1,308.00
3,068.00
2,089.00
13,072.00
6,517.00
5,094
Net Operating Cash Flow
12,246.00
8,756.00
10,605.00
3,758.00
20,849.00
10,142
Capital Expenditures
142.00
873.00
1,328.00
1,723.00
1,564.00
Sale of Fixed Assets & Businesses
-
21.00
-
46.00
31.00
Purchase/Sale of Investments
-
83.00
38,081.00
10,537.00
14,480.00
Net Investing Cash Flow
142.00
935.00
39,409.00
9,860.00
15,214.00
Issuance/Reduction of Debt, Net
-
-
102.00
196.00
688.00
Net Financing Cash Flow
2,378.00
14,502.00
43,797.00
231.00
18,729.00
Net Change in Cash
9,947.00
4,810.00
6,217.00
5,871.00
13,094.00
Free Cash Flow
12,388.00
9,629.00
11,933.00
5,373.00
22,413.00
Other Sources
-
-
-
1,000.00
2,267.00
Change in Capital Stock
2,378.00
14,502.00
43,695.00
77.00
19,329.00
Exchange Rate Effect
63.00
1.00
-
-
-
About MediGene
View Profile
